GGrantIndex
← Leaderboards

Seth Joel Corey

Children'S Hosp Pittsburgh/Upmc Hlth Sys

$6,631,626
Attributed
$8,547,382
Total exposure
9
Grants
7
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $988K · FY200525
$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$8,547,382 · 9

By mechanism

R01$7,136,066 · 4
R21$817,836 · 2
K02$295,488 · 1
R29$198,321 · 1
P30$99,671 · 1

Top collaborators

Others in their field

Top investigators on “Genes

Research focus

GenesAffectHematopoiesisPhenotypeFunctional DisorderGeneticBaseMyelogenousCellsMutationLifeGrowthNeutropeniaInsightApoptosisMolecularSignal TransductionLeadInnovationLaboratoriesCell LineCell DeathMalignant - DescriptorComplex

Grant awards (35)

Genetic Dissection of Stress Responses in Shwachman-Diamond Syndrome$231,801
R01 · FY2025 · DK · contact PI
Genetic Dissection of Stress Responses in Shwachman-Diamond Syndrome$227,857
R01 · FY2024 · DK · contact PI
Genetic Dissection of Stress Responses in Shwachman-Diamond Syndrome$241,500
R01 · FY2023 · DK · contact PI
Multiscale Modeling of Myelodysplastic Syndromes$847,513
R01 · FY2019 · HL · contact PI
Multiscale Modeling of Myelodysplastic Syndromes$713,684
R01 · FY2018 · HL · contact PI
Cancer Molecular Genetics Program$12,843
P30 · FY2018 · CA · contact PI
Cancer Molecular Genetics Program$11,991
P30 · FY2018 · CA · contact PI
Cancer Molecular Genetics Program$5,070
P30 · FY2018 · CA · contact PI
Multiscale Modeling of Myelodysplastic Syndromes$729,676
R01 · FY2017 · HL · contact PI
Cancer Molecular Genetics Program$69,767
P30 · FY2017 · CA · contact PI
Multiscale Modeling of Myelodysplastic Syndromes$749,005
R01 · FY2016 · HL · contact PI
Multiscale Modeling of Myelodysplastic Syndromes$791,635
R01 · FY2015 · HL · contact PI
Genetic Modifiers for Cancer Stem Cells in Secondary MDS/AML$168,839
R21 · FY2015 · CA · contact PI
Genetic Modifiers for Cancer Stem Cells in Secondary MDS/AML$27,567
R21 · FY2015 · CA · contact PI
Genetic Modifiers for Cancer Stem Cells in Secondary MDS/AML$177,197
R21 · FY2014 · CA · contact PI
The F-BAR protein CIP4 in WAS-dependent thrombocytopenia$195,095
R21 · FY2012 · HL · contact PI
The F-BAR protein CIP4 in WAS-dependent thrombocytopenia$249,138
R21 · FY2011 · HL · contact PI
Targeted Therapy of Lyn in Myelodysplastic Syndrome$264,940
R01 · FY2010 · CA · contact PI
Targeted Therapy of Lyn in Myelodysplastic Syndrome$278,065
R01 · FY2008 · CA · contact PI
Targeted Therapy of Lyn in Myelodysplastic Syndrome$258,530
R01 · FY2008 · CA · contact PI
Scaffolding Proteins in Macrophage Phagocytosis$209,190
R01 · FY2008 · HL · contact PI
Scaffolding Proteins in Macrophage Phagocytosis$123,393
R01 · FY2008 · HL · contact PI
Scaffolding Proteins in Macrophage Phagocytosis$322,143
R01 · FY2007 · HL · contact PI
Targeted Therapy of Lyn in Myelodysplastic Syndrome$258,530
R01 · FY2007 · CA · contact PI
Scaffolding Proteins in Macrophage Phagocytosis$294,903
R01 · FY2006 · HL · contact PI
Targeted Therapy of Lyn in Myelodysplastic Syndrome$266,250
R01 · FY2006 · CA · contact PI
Scaffolding Proteins in Macrophage Phagocytosis$25,451
R01 · FY2006 · HL · contact PI
Scaffolding Proteins in Macrophage Phagocytosis$302,000
R01 · FY2005 · HL
PROTEIN TYROSINE KINASES IN LEUKO PROLIF AND APOPTOSIS$59,923
K02 · FY2002 · HL
PROTEIN TYROSINE KINASES IN LEUKO PROLIF AND APOPTOSIS$38,573
K02 · FY2002 · HL
PROTEIN TYROSINE KINASES IN LEUKO PROLIF AND APOPTOSIS$98,496
K02 · FY2001 · HL
LYN AND JAK2 IN GCSF PROLIFERATIVE SIGNALING$68,469
R29 · FY2001 · CA
LYN AND JAK2 IN GCSF PROLIFERATIVE SIGNALING$31,852
R29 · FY2001 · CA
PROTEIN TYROSINE KINASES IN LEUKO PROLIF AND APOPTOSIS$98,496
K02 · FY2000 · HL
LYN AND JAK2 IN GCSF PROLIFERATIVE SIGNALING$98,000
R29 · FY2000 · CA